CD39L1

CD39L1, also known as ecto-nucleoside triphosphate diphosphohydrolase 1-like 1, is a protein-coding gene. It belongs to the ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) family, which are enzymes that hydrolyze extracellular nucleoside triphosphates and diphosphates. These enzymes play a crucial role in regulating purinergic signaling, a system that uses adenosine triphosphate (ATP) and adenosine diphosphate (ADP) as signaling molecules. CD39L1 specifically acts on ATP and ADP, converting them into adenosine monophosphate (AMP) and then further to adenosine.

The protein encoded by the CD39L1 gene is thought to be a transmembrane glycoprotein. Its precise physiological functions are still under investigation, but it is believed to be involved in processes such as platelet aggregation, inflammation, and immune responses. Dysregulation of purinergic signaling, which CD39L1 influences, has been implicated in various pathological conditions, including cardiovascular diseases and cancer. Research into CD39L1 is ongoing to better understand its role in cellular processes and its potential as a therapeutic target.